aranesp
Generic: darbepoetin alfa
Labeler: amgen, incDrug Facts
Product Profile
Brand Name
aranesp
Generic Name
darbepoetin alfa
Labeler
amgen, inc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
darbepoetin alfa 150 ug/.3mL
Manufacturer
Identifiers & Regulatory
Product NDC
55513-027
Product ID
55513-027_7023e5d7-0f00-4fa4-8223-fa77bee46feb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA103951
Listing Expiration
2027-12-31
Marketing Start
2006-09-11
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55513027
Hyphenated Format
55513-027
Supplemental Identifiers
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
aranesp (source: ndc)
Generic Name
darbepoetin alfa (source: ndc)
Application Number
BLA103951 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 ug/.3mL
Packaging
- 1 BLISTER PACK in 1 PACKAGE (55513-027-04) / 4 SYRINGE in 1 BLISTER PACK / .3 mL in 1 SYRINGE (55513-027-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "7023e5d7-0f00-4fa4-8223-fa77bee46feb", "openfda": {"nui": ["N0000175665", "M0007726", "N0000009319"], "upc": ["0355513006019"], "unii": ["15UQ94PT4P"], "spl_set_id": ["0fd36cb9-c4f6-4167-93c9-8530865db3f9"], "pharm_class_cs": ["Erythropoietin [CS]"], "pharm_class_pe": ["Increased Erythroid Cell Production [PE]"], "pharm_class_epc": ["Erythropoiesis-stimulating Agent [EPC]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 PACKAGE (55513-027-04) / 4 SYRINGE in 1 BLISTER PACK / .3 mL in 1 SYRINGE (55513-027-01)", "package_ndc": "55513-027-04", "marketing_start_date": "20060911"}], "brand_name": "ARANESP", "product_id": "55513-027_7023e5d7-0f00-4fa4-8223-fa77bee46feb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Erythropoiesis-stimulating Agent [EPC]", "Erythropoietin [CS]", "Increased Erythroid Cell Production [PE]"], "product_ndc": "55513-027", "generic_name": "darbepoetin alfa", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ARANESP", "active_ingredients": [{"name": "DARBEPOETIN ALFA", "strength": "150 ug/.3mL"}], "application_number": "BLA103951", "marketing_category": "BLA", "marketing_start_date": "20060911", "listing_expiration_date": "20271231"}